- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Oxidative Medicine and Cellular Longevity
Volume 2012 (2012), Article ID 373450, 3 pages
Oxidative Stress in Cardiovascular Pathologies: Genetics, Cellular, and Molecular Mechanisms and Future Antioxidant Therapies
1Department of Genomics, Transcriptomics, and Molecular Therapies, Molecular and Cellular Pharmacology, Functional Genomics Laboratory, Institute of Cellular Biology and Pathology “Nicolae Simionescu,” 8 BP Hasdeu Street, 050568 Bucharest, Romania
2Division of Cardiovascular Sciences, Center for Applied Medical Research, University of Navarra, Pio XII, 31008 Pamplona, Spain
3Vascular Research Laboratory, Fundación Jiménez Diaz, Autonomous University of Madrid, Avenida Reyes Católicos 2, 28040 Madrid, Spain
Received 23 December 2012; Accepted 23 December 2012
Copyright © 2012 Adrian Manea et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- D. D. Heistad, Y. Wakisaka, J. Miller, Y. Chu, and R. Pena-Silva, “Novel aspects of oxidative stress in cardiovascular diseases,” Circulation Journal, vol. 73, no. 2, pp. 201–207, 2009.
- M. Simionescu, “Implications of early structural-functional changes in the endothelium for vascular disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 2, pp. 266–274, 2007.
- J. Madrigal-Matute, C. E. Fernandez-Garcia, C. Gomez-Guerrero et al., “HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis,” Cardiovascular Resarch, vol. 95, no. 1, pp. 116–123, 2012.
- A. Fortuño, J. Bidegain, A. Baltanás et al., “Is leptin involved in phagocytic NADPH oxidase overactivity in obesity? Potential clinical implications,” Journal of Hypertension, vol. 28, no. 9, pp. 1944–1950, 2010.
- A. Manea and M. Simionescu, “Nox enzymes and oxidative stress in atherosclerosis,” Frontiers in Bioscience, vol. 4, pp. 651–670, 2012.
- A. Manea, “NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology,” Cell and Tissue Research, vol. 342, no. 3, pp. 325–339, 2010.
- A. C. Montezano and R. M. Touyz, “Molecular mechanisms of hypertension—reactive oxygen species and antioxidants: a basic science update for the clinician,” Canadian Journal of Cardiology, vol. 28, no. 3, pp. 288–295, 2012.
- U. Förstermann, “Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies,” Nature Clinical Practice Cardiovascular Medicine, vol. 5, no. 6, pp. 338–349, 2008.
- I. M. Fearon and S. P. Faux, “Oxidative stress and cardiovascular disease: novel tools give (free) radical insight,” Journal of Molecular and Cellular Cardiology, vol. 47, no. 3, pp. 372–381, 2009.
- I. M. Fenyo, I. C. Florea, M. Raicu, and A. Manea, “Tyrphostin AG490 reduces NAPDH oxidase activity and expression in the aorta of hypercholesterolemic apolipoprotein E-deficient mice,” Vascular Pharmacology, vol. 54, no. 3–6, pp. 100–106, 2011.